Amineptine treatment of persistent catatonic symptoms in schizophrenia: A controlled study

Neuropsychopharmacologia Hungarica

Volumn 12, Issue 4, 2010, Pages 463-467

  Ungvari, Gabor S ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Amineptine; Catatonia; Schizophrenia

Indexed keywords

AMINEPTINE; NEUROLEPTIC AGENT; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADD ON THERAPY; ARTICLE; CATATONIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; NEGATIVE SYNDROME; OUTCOME ASSESSMENT; RATING SCALE; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT RESPONSE;

ADULT; AGED; BASAL GANGLIA DISEASES; CROSS-OVER STUDIES; DIBENZOCYCLOHEPTENES; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; SCHIZOPHRENIA, CATATONIC; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT FAILURE;

EID: 78651349955     PISSN: 14198711     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Andreasen NC. The Scale for Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa Press, 1983.
2. APA. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. APA, Washington, DC: American Psychiatric Association, 1994.
3. Astrup C. The Chronic Schizophrenias. Oslo: Universitatsforlaget; 1979.
4. Ban TA: Clinical pharmacology and Leonhard's classification of endogenous psychoses. Psychopathology. 1009; 23: 331-8.
5. Beckmann H, Fritze J, Franzek E: The influence of neuroleptics on specific syndromes and symptoms in schizophrenics with unfavourable long-term course. A 5-year follow-up study of 50 chronic schizophrenics. Neuropsychobiology. 1992; 26:50-8.
6. Bonnet JJ, Chagraoui A, Protais P, Constantin J. Interactions of amineptine with the neuronal dopamine uptake system: neurochemical in vitro and in vivo studies. J Neur Transmission. 1987; 69: 211-20. (Pubitemid 17087655)
7. Bush G, Fink, M, Petrides G, Dowling F, Francis, A: 1996. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand. 93 129-136.
8. Bush G, Petrides G, Francis A: Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophr Res. 1997; 27: 83-92. (Pubitemid 27465726)
9. Caroff SN, Mann SC, Francis A, Fricchione GL: Catatonia. From Psychopathology to Neurobiology. American Psychiatric Publishing Inc., Washington, 2004.
10. Cohen D, Nicolas J-D, Flament MF, Perisse D, Dubos P-F, Bonnot O, Speranza M, Graindorge C, Tordjman S, Mazet P: Clinical relevance of chronic catatonic schizophrenia in children and adolescents: evidence from a prospective naturalistic study. Schiz Res. 2005; 76:301-8. (Pubitemid 40804776)
11. Deniker P, Loo H, Zarifian E, Peron P, Benyacoumb A, Roux JM., Kamoun A: Amineptine and amotivational syndrome. Encephale 1981; 7: 59-64.
12. Fink M, Taylor MA: Catatonia. A Clinician's Guide to Diagnosis and Treatment. Cambridge University Press, Cambridge-New York, NY, 2003.
13. Fish FJ: The influence of tranquilizers on the Leonhard schizophrenia syndromes. Encephale. 1964; 53: 245-9.
14. Franz M, Gallhofer B, Kanzow WT: Treatment of catatonia with intravenous biperidene. Brit J Psychiatry. 1994; 164: 847-8.
15. Guy W: NECDEU Assessment Manual for Psychopharmacology. Rockville, MD: ADAMHA, US DHEW Publication (ADM); 1976; pp. 76-338.
16. Hirschberg E: Zur Frage psychischer Wirkungsqualitaten des Akinetons im Rahmen neuroleptischen Pharmakotherapie. Nervenarzt. 1964: 35: 419-20.
17. Hoffler J, Braunig P, Borner I, Kruger S: Untersuchung zum Einfluss veranderter diagnostischer kriterien auf die Haufigkeit der Diagnose "katatone Schizophrenie". In: Braunig P. (Ed) Differenzierung katatoner und neuroleptika-induzierter Bewegungsstorungen. Stuttgart: G Thieme, 1995, pp. 43-6.
18. McKenna PJ, Lund CE, Mortimer AM, Biggins CA: Motor, volitional and behavioural disorders in schizophrenia 2: The "conflict of paradigms" hypothesis. Brit J Psychiatry. 1991; 158: 328-36.
19. Munetz MR, Benjamin S: How to examine patients using the Abnormal Involuntary Movement Scale. Hosp Comm Psychiatry. 1988; 39:112-7.
20. Prieto JM, Gost A, Obiols J, Caycedo N: Amineptine dependence and schizophrenia. Biol Psychiatry. 1994; 36: 266-8.
21. Rosebush PI, Mazurek MF: Pharmacotherapy. In: Caroff SN, Mann SC, Francis A, Fricchione GL, editors. Catatonia. From Psychopathology to Neurobiology. Washington: American Psychiatric Publishing Inc.; 2004, pp. 141-50.
22. Rosebush PI, Mazurek FM: Catatonia and its treatment. Schiz Bull. 2010; 36:314-20.
23. Simpson GM, Angus JWS: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand. 1970; 45(Suppl. 212): 11-9.
24. Singh SP, Singh V, Kar N, Chan K: Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis. Br J Psychiatry. 2010; 197: 1741-79.
25. Taylor MA, Fink M: Catatonia in psychiatric classification: implications of recent research. Am J Psychiatry, 2003; 160: 1233-41.
26. Ungvari GS, Chiu, HFK, Chow, LY, Lau, B, Tang WK: Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study. Psychopharmacology. 1999; 142: 393-8. (Pubitemid 29187628)
27. Ungvari GS, Leung SK, Ng FS, Cheung HK, Leung T: Schizophrenia with prominent catatonic features ('catatonic schizophrenia'). I. Demographic and clinical correlates in the chronic phase. Progr Neuro-Psychopharmacol & Biol Psychiatry. 2005; 29: 27-38.
28. Ungvari GS, Caroff SN, Gerevich J: The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schiz Bull. 2010; 36: 231-8.
29. Volterra V, Paoli MT: Effects of amineptine in schizophrenic patients with passivity, depression, defectiveness and chronic extrapyramidal syndromes undergoing prolonged neuroleptic treatment. Curr Ther Research. 1990; 47: 252-60. (Pubitemid 20074851)
30. Williams JBW: A structured interview guide for the Hamilton Depression Rating Scale. Arch gen Psychiatry. 1988; 45: 742-5.
31. Winter E, Grosse R: Zur Wirkung von Biperiden bei akuten substuporos-stuporosen Zustanden. Pharmacopsychiatry. 1979; 12: 383-7. (Pubitemid 10237681)
32. Woerner MG, Manuzza S, Kane JM: Anchoring the BPRS: an aid to improved reliability. Psychopharmacol Bull. 1988; 24:112-7.
33. Wong E, Ungvari GS, Leung SK, Tang WK: Rating catatonia in patients with chronic schizophrenia: Rasch analysis of the Bush-Francis Catatonia Rating Scale. Int J Methods Psychiatry Res 2007; 16: 161-70. (Pubitemid 47457076)